Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y0PE
|
|||
| Drug Name |
PMID25656651-Compound-46
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
TERRABAY PHARMACEUTICALS, INC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C31H24F5N7O
|
|||
| Canonical SMILES |
CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C4CC(C4)(F)F)NC5=NC=CC(=N5)C6=CN=CC=C6
|
|||
| InChI |
1S/C31H24F5N7O/c1-18-4-5-19(9-26(18)42-29-38-8-6-25(41-29)20-3-2-7-37-15-20)28(44)40-23-10-22(31(34,35)36)11-24(12-23)43-16-27(39-17-43)21-13-30(32,33)14-21/h2-12,15-17,21H,13-14H2,1H3,(H,40,44)(H,38,41,42)
|
|||
| InChIKey |
FHMNIXSTLJZGDP-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.